Walvax Biotechnology Co., Ltd. announced that it will issue convertible bonds for gross proceeds of up to CNY 1,200,000,000 on August 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.84 CNY | -2.12% | -2.95% | -41.13% |
10:10am | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
Apr. 25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.13% | 3.06B | |
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-19.73% | 29.48B | |
+57.86% | 25.43B | |
-17.66% | 11.49B | |
-44.02% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
-8.42% | 7.99B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Walvax Biotechnology Co., Ltd. announced that it expects to receive CNY 1.2 billion in funding